FDA Approves New PARP Inhibitor for Ovarian Cancer
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
Month: March 2017
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will...
As part of a growing public affairs program, the American Association for Cancer Research is excited to once again...
A big career fair can be somewhat intimidating, so we asked some hiring experts for their advice on how...
At the 2017 Annual Meeting, the AACR is expanding its social media profile to include Snapchat and Instagram.
In addition to the robust scientific program at this year’s AACR Annual Meeting in Washington, D.C., a number of...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...
The American Association for Cancer Research was shocked last week to learn that the Trump administration has proposed to...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
The AACR has a robust program of educational workshops designed to equip early-career investigators with the knowledge, skills, and...